Association between Lipoprotein-Associated Phospholipase A 2 Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population

Annals of Human Genetics

Volumn 75, Issue 5, 2011, Pages 605-611

  Li, Liyun ^a   Qi, Liping ^a   Lv, Naqiang ^b   Gao, Qian ^b   Cheng, Yanmei ^b   Wei, Yingjie ^b   Ye, Jue ^b   Yan, Xiaowei ^a   Dang, Aimin ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

Coronary artery disease; Haplotype; Lipoprotein associated phospholipase A 2; Single nucleotide polymorphism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPASE A2; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FAMILY HISTORY; FEMALE; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEART INFARCTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80051559505     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2011.00666.x     Document Type: Article

References (29)

1. Abuzeid, A. M., Hawe, E., Humphries, S. E., Talmud, P. J.; HIFMECH Study Group. (2003) Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe. Atherosclerosis 168, 283-288.
2. Blankenberg, S., Stengel, D., Rupprecht, H. J., Bickel, C., Meyer, J., Cambien, F., Tiret, L. & Ninio, E. (2003) Plasma PAF-acetylhydrolase in patients with coronary artery disease. Results of a cross-sectional analysis. J Lipid Res 44, 1381-1386.
3. Carpenter, K. L., Dennis, I. F., Challis, I. R., Osborn, D. P., Macphee, C. H., Leake, D. S., Arends, M. J. & Mitchinson, M. J. (2001) Inhibition of lipoprotein-associated phospholipase A2 diminishes the death-inducing effects of oxidized LDL on human monocyte-macrophages. FEBS Lett 505, 357-363.
4. Casas, J. P., Ninio, E., Panayiotou, A., Palmen, J., Cooper, J. A., Ricketts, S. L., Sofat, R., Nicolaides, A. N., Corsetti, J. P., Fowkes, F. G., Tzoulaki, I., Kumari, M., Brunner, E. J., Kivimaki, M., Marmot, M. G., Hoffmann, M. M., Winkler, K., Marz, W., Ye, S., Stirnadel, H. A., Boekholdt, S. M., Khaw, K. T., Humphries, S. E., Sandhu, M. S., Hingorani, A. D. & Talmud, P. J. (2010) PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10494 cases and 15624 controls of European ancestry. Circulation 121, 2284-2293.
5. Caslake, M. J., Packard, C. J., Suckling, K. E., Holmes, S. D., Chamberlain, P. & Macphee, C. H. (2000) Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: A potential new risk factor for coronary artery disease. Atherosclerosis 150, 413-419.
6. Hou, L., Chen, S., Yu, H., Lu, X., Chen, J., Wang, L., Huang, J., Fan, Z. & Gu, D. (2009) Associations of PLA2G7 gene polymorphisms with plasma lipoprotein-associated phospholipase A2 activity and coronary heart disease in a Chinese Han population: The Beijing atherosclerosis study. Hum genet 125, 11-20.
7. Jang, Y., Kim, O. Y., Koh, S. J., Chae, J. S., Ko, Y. G., Kim, J. Y., Cho, H., Jeong, T. S., Lee, W. S., Ordovas, J. M. & Lee, J. H. (2006) The Val279Phe variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men. J Clin Endocrinol Metab 91, 3521-3527.
8. Kruse, S., Mao, X. Q., Heinzmann, A., Blattmann, S., Roberts, M. H., Braun, S., Gao, P. S., Forster, J., Kuehr, J., Hopkin, J. M., Shirakawa, T. & Deichmann, K. A. (2000) The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma. Am J Hum Genet 66, 1522-1530.
9. Liu, P. Y., Li, Y. H., Wu, H. L., Chao, T. H., Tsai, L. M., Lin, L. J., Shi, G. Y. & Chen, J. H. (2006) Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction. J Thromb Haemost 4, 1023-1028.
10. MacPhee, C. H., Moores, K. E., Boyd, H. E., Dhanak, D., Ife, R. J., Leach, C. A., Leake, D. S., Milliner, K. J., Patterson, R. A., Suckling, K. E., Tew, D. G. & Hickey, D. M. (1999) Lipoprotein-associated phospholipase A2, platelet-activating factor Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: Use of a novel inhibitor. Biochem J 338(Pt 2), 479-487.
11. 2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: The results of a multicenter, randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 51, 1632-1641.
12. Ninio, E., Tregouet, D., Carrier, J. L., Stengel, D., Bickel, C., Perret, C., Rupprecht, H. J., Cambien, F., Blankenberg, S. & Tiret, L. (2004) Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Hum Mol Genet 13, 1341-1351.
13. Noto, H., Hara, M., Karasawa, K., Iso-O, N., Satoh, H., Togo, M., Hashimoto, Y., Yamada, Y., Kosaka, T., Kawamura, M., Kimura, S. & Tsukamoto, K. (2003) Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress. Arterioscler Thromb Vasc Biol 23, 829-835.
14. Packard, C. J., O'Reilly, D. S., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., Rumley, A. & Lowe, G. D. (2000) Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 343, 1148-11455.
15. Paik, J. K., Chae, J. S., Jang, Y., Kim, J. Y., Kim, O. Y., Jeong, T. S., Lee, S. H. & Lee, J. H. (2010) Effects of V279F in the Lp-PLA(2) gene on markers of oxidative stress and inflammation in Koreans. Clin Chim Acta 411, 486-493.
16. Quarck, R., De Geest, B., Stengel, D., Mertens, A., Lox, M., Theilmeier, G., Michiels, C., Raes, M., Bult, H., Collen, D., Van Veldhoven, P., Ninio, E. & Holvoet, P. (2001) Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation 103, 2495-2500.
17. Satoh, K., Yoshida, H., Imaizumi, T., Takamatsu, S. & Mizuno, S. (1992) Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke. Stroke 23, 1090-1092.
18. Serruys, P. W., Garcia-Garcia, H. M., Buszman, P., Erne, P., Verheye, S., Aschermann, M., Duckers, H., Bleie, O., Dudek, D., Botker, H. E., von Birgelen, C., D'Amico, D., Hutchinson, T., Zambanini, A., Mastik, F., van Es, G. A., van der Steen, A. F., Vince, D. G., Ganz, P., Hamm, C. W., Wijns, W., Zalewski, A.; Integrated Biomarker and Imaging Study-2 Investigators. (2008) Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 118, 1172-1182.
19. Shi, Y. Y. & He, L. (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15, 97-98.
20. Shimokata, K., Yamada, Y., Kondo, T., Ichihara, S., Izaws, H., Nagata, K., Murohara, T., Ohno, M. & Yokota, M. (2004) Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis 172, 167-173.
21. Stafforini, D. M., McIntyre, T. M., Zimmerman, G. A. & Prescott, S. M. (2003) Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40, 643-672.
22. Stafforini, D. M., Prescott, S. M., Zimmerman, G. A. & McIntyre, T. M. (1991) Platelet-activating factor acetylhydrolase activity in human tissues and blood cells. Lipids 26, 979-985.
23. Stafforini, D. M., Satoh, K., Atkinson, D. L., Tjoelker, L. W., Eberhardt, C., Yoshida, H., Imaizumi, T., Takamatsu, S., Zimmerman, G. A., McIntyre, T. M., Gray, P. W. & Prescott, S. M. (1996) Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest 97, 2784-2791.
24. The Lp-PLA2 Studies Collaboration, Thompson, A., Gao, P., Orfei, L., Watson, S., Di Angelantonio, E., Kaptoge, S., Ballantyne, C., Cannon, C. P., Criqui, M., Cushman, M., Hofman, A., Pachard, C., Thompson, S. G., Collins, R. & Danesh, J. (2010) Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: Collaborative analysis of 32 prospective studies. Lancet 375, 1536-1544.
25. Tjoelker, L. W., Eberhardt, C., Unger, J., Trong, H. L., Zimmerman, G. A., McIntyre, T. M., Stafforini, D. M., Prescott, S. M. & Gray, P. W. (1995a) Plasma plateletactivating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem 270, 25481-25487.
26. Tjoelker, L. W., Wilder, C., Eberhardt, C., Stafforini, D. M., Dietsch, G., Schimpf, B., Hooper, S., Le Trong, H., Cousens, L. S. & Zimmerman, G. A. (1995b) Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374, 549-553.
27. Yamada, Y., Ichihara, S., Fujimura, T. & Yokota, M. (1998) Identification of the G994/T missense mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men. Metabolism 47, 177-181.
28. Yamada, Y., Yoshida, H., Ichihara, S., Imaizumi, T., Satoh, K. & Yokota, M. (2000) Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age and atherosclerosis in a Japanese population. Atherosclerosis 150, 209-216.
29. Yanoshita, R., Kudo, I., Ikizawa, K., Chang, H.W., Kobayashi, S., Ohno, M., Nojima, S. & Inoue, K. (1988) Hydrolysis of platelet-activating factor and its methylated analogs by acetylhydrolases. J Biochem 103, 815-819.